Anchor Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,685
| Closed | -$218K | – | 271 |
|
|
2023
Q1 | $218K | Hold |
1,685
| – | – | 0.01% | 259 |
|
|
2022
Q4 | $221K | Buy |
+1,685
| New | +$221K | 0.01% | 257 |
|
|
2022
Q3 | – | Sell |
-2,135
| Closed | -$251K | – | 274 |
|
|
2022
Q2 | $251K | Sell |
2,135
-75
| -3% | -$8.82K | 0.01% | 255 |
|
|
2022
Q1 | $288K | Sell |
2,210
-2,500
| -53% | -$326K | 0.01% | 253 |
|
|
2021
Q4 | $719K | Sell |
4,710
-300
| -6% | -$45.8K | 0.01% | 207 |
|
|
2021
Q3 | $810K | Sell |
5,010
-225
| -4% | -$36.4K | 0.02% | 191 |
|
|
2021
Q2 | $857K | Hold |
5,235
| – | – | 0.02% | 191 |
|
|
2021
Q1 | $788K | Hold |
5,235
| – | – | 0.02% | 195 |
|
|
2020
Q4 | $793K | Buy |
5,235
+1,015
| +24% | +$154K | 0.02% | 191 |
|
|
2020
Q3 | $571K | Buy |
+4,220
| New | +$571K | 0.01% | 195 |
|